Yanyan Liu

This study tests a new combination of two targeted drugs (linperlisib and chidamide) against standard chemotherapy for people with a rare type of blood cancer called peripheral T-cell lymphoma. The goal is to see if the new combo works better at shrinking tumors and controlling t…